机构:[1]Guangzhou Univ Chinese Med, State Key Lab Dampness Syndrome Chinese Med, Clin Coll 2, Guangzhou, Peoples R China广东省中医院[2]Guangzhou Univ Chinese Med, Affiliated Hosp 2, Guangzhou, Peoples R China广东省中医院[3]Guangdong Prov Acad Chinese Med Sci, Bone & Joint Res Team Degenerat & Injury, Guangzhou, Peoples R China广东省中医院[4]Guangdong Second Tradit Chinese Med Hosp, Guangdong Prov Engn Technol Res Inst Tradit Chines, Guangzhou, Peoples R China广东省中医院
Knee osteoarthritis (KOA) is a common geriatric disease in middle-aged and elderly people. Its main pathological characteristics are articular cartilage degeneration, changes in subchondral bone reactivity, osteophyte formation at joint edges, synovial disease, ligament relaxation or contracture, and joint capsular contracture. The prevalence rate of symptomatic KOA in middle-aged and elderly people in China is 8.1%, and this is increasing. The main clinical manifestations of this disease are pain and limited activity of the knee joint, which seriously affect the quality of life of patients and may cause disability, posing a huge burden on society and the economy. Although the pathogenesis of KOA is not clear, the treatment of KOA is diverse, and Chinese medicine, which mainly relies on plant-based natural products, has a relatively stable and reliable curative effect. This guideline aims to emphasize the evidence-based staging and stepped treatment of KOA and the therapeutic effect of integrative medicine based on traditional Chinese medicine on KOA. We make recommendations that include the adoption of manual therapy, acupuncture, external application of herbs, herbal plasters, exercise therapy, and other integrative medicine based on traditional Chinese medicine. Users of the above guidelines are most likely to include clinicians and health managers in healthcare settings.
基金:
This work was supported by the Research Fund for Bajian Talents of Guangdong Provincial Hospital of Chinese Medicine (No. BJ2022KY01), Special project of State Key Laboratory of Dampness Syndrome of Chinese Medicine & Administration of Traditional Chinese Medicine of Guangdong Province (Nos. 20225025 and 20231109), the Science and Technology Research Project of Guangdong Provincial Hospital of Chinese Medicine (Nos. YN2019ML08, YN2022GK05, and YN2020MS16), Guangdong Basic and Applied Basic Research Foundation (No. 2022A1515220131), Medical Scientific Research Foundation of Guangdong Province (No. 202303211022372094), Project of Philosophy and Social Science Planning of Guangzhou in 2022 (No. 2022GZQN42), National Natural Science Foundation of China (No. 82004383), and China Postdoctoral Science Foundation (No. 2018M633036).
第一作者机构:[1]Guangzhou Univ Chinese Med, State Key Lab Dampness Syndrome Chinese Med, Clin Coll 2, Guangzhou, Peoples R China[2]Guangzhou Univ Chinese Med, Affiliated Hosp 2, Guangzhou, Peoples R China[3]Guangdong Prov Acad Chinese Med Sci, Bone & Joint Res Team Degenerat & Injury, Guangzhou, Peoples R China
通讯作者:
通讯机构:[1]Guangzhou Univ Chinese Med, State Key Lab Dampness Syndrome Chinese Med, Clin Coll 2, Guangzhou, Peoples R China[2]Guangzhou Univ Chinese Med, Affiliated Hosp 2, Guangzhou, Peoples R China[3]Guangdong Prov Acad Chinese Med Sci, Bone & Joint Res Team Degenerat & Injury, Guangzhou, Peoples R China[4]Guangdong Second Tradit Chinese Med Hosp, Guangdong Prov Engn Technol Res Inst Tradit Chines, Guangzhou, Peoples R China
推荐引用方式(GB/T 7714):
Zeng Lingfeng,Zhou Guanghui,Yang Weiyi,et al.Guidelines for the diagnosis and treatment of knee osteoarthritis with integrative medicine based on traditional Chinese medicine[J].FRONTIERS IN MEDICINE.2023,10:doi:10.3389/fmed.2023.1260943.
APA:
Zeng, Lingfeng,Zhou, Guanghui,Yang, Weiyi,Liu, Jun&China Association for Chinese Medicine.(2023).Guidelines for the diagnosis and treatment of knee osteoarthritis with integrative medicine based on traditional Chinese medicine.FRONTIERS IN MEDICINE,10,
MLA:
Zeng, Lingfeng,et al."Guidelines for the diagnosis and treatment of knee osteoarthritis with integrative medicine based on traditional Chinese medicine".FRONTIERS IN MEDICINE 10.(2023)